IP Library Granted Patent US 9,585,611
Granted Patent B2
US 9,585,611 · App. 14/262,449 · Granted Mar 7, 2017

Detecting seizures based on heartbeat data

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,585,611
App. No.
14/262,449
Granted
Mar 7, 2017
Kind
B2
Abstract

A method includes receiving heartbeat data of a patient and receiving activity data of the patient. The activity data includes one or more activity values that are related to an activity level of the patient and that are measured independently of the heartbeat data. The method further includes determining a value of a weighting factor based on the activity data. The method also includes determining modified heartbeat data by applying the weighting factor to at least a portion of the heartbeat data. The method also includes detecting a seizure event based on the modified heartbeat data.

Claims (42)

1. A method comprising:

receiving heartbeat data of a patient;

receiving activity data of the patient, wherein the activity data includes an activity value related to an activity level of the patient that is measured independently of the heartbeat data;

determining one of a plurality of activity value ranges to which the activity value belongs;

determining a weighting factor based on the determined activity value range, each of the plurality of activity value ranges associated with a different one of a plurality of predetermined weighting factors;

determining modified heartbeat data by applying the weighting factor to at least a portion of the heartbeat data; and

detecting a seizure event based on the modified heartbeat data.

2. The method of claim 1 , wherein determining the modified heartbeat data includes determining a background (BG) heart rate based on a previously-determined BG heart rate, a most recent R-R interval, and the weighting factor.

3. The method of claim 2 , wherein the BG heart rate is determined as a sum of a first value and a second value, wherein the first value is the weighting factor times the previously-determined BG heart rate and the second value is one minus the weighting factor times the most recent R-R interval.

4. The method of claim 2 , wherein determining the modified heartbeat data further includes determining a foreground (FG) heart rate based on one or more R-R intervals of the heartbeat data.

5. The method of claim 4 , wherein detecting the seizure event comprises comparing a ratio of the FG heart rate and the BG heart rate to a seizure detection threshold.

6. The method of claim 1 , wherein the heartbeat data of the patient includes electrocardiogram data.

7. The method of claim 6 , wherein the electrocardiogram data indicates a timing related to a plurality of R-waves.

8. The method of claim 1 , further comprising detecting an indication of noise in the heartbeat data, wherein the weighting factor is determined further based on the indication of noise in the heartbeat data.

9. The method of claim 8 , wherein:

in response to detecting an increase in the noise in the heartbeat data, the value of the weighting factor is determined such that an effect of prior heartbeat data on the modified heartbeat data is decreased; and

in response to detecting a decrease in the noise in the heartbeat data, the value of the weighting factor is determined such that the effect of the prior heartbeat data on the modified heartbeat data is increased.

10. The method of claim 1 , further comprising causing, in response to the detection of the seizure event, initiating at least one of a stimulation to tissue of the patient, a reporting of the occurrence of the seizure event, and a recording of the seizure event.

11. The method of claim 1 , wherein the activity data includes accelerometer data, body temperature data, electromyography data, perspiration data, impedance data, or a combination thereof.

12. The method of claim 1 , wherein in response to the activity data indicating an increased activity level of the patient, the value of the weighting factor is determined such that an effect of prior heartbeat data on the modified heartbeat data is decreased.

13. A medical device comprising:

a first interface to receive heartbeat data of a patient;

a second interface to receive activity data of the patient, wherein the activity data includes an activity value related to an activity level of the patient that is measured independently of the heartbeat data; and

a processor configured to:

determine one of a plurality of activity value ranges to which the activity value belongs;

determine a weighting factor based on the determined activity value range, each of the plurality of activity value ranges associated with a different one of a plurality of predetermined weighting factors;

determine modified heartbeat data by applying the weighting factor to at least a portion of the heartbeat data; and

detect a seizure event based on the modified heartbeat data.

14. The medical device of claim 13 , wherein determining the modified heartbeat data includes determining a background (BG) heart rate based on a previously-determined BG heart rate, a most recent R-R interval, and the weighting factor.

15. The medical device of claim 14 , wherein the BG heart rate is determined as a sum of a first value and a second value, wherein the first value is the weighting factor times the previously-determined BG heart rate and the second value is one minus the weighting factor times the most recent R-R interval.

16. The medical device of claim 14 , wherein determining the modified heartbeat data further includes determining a foreground (FG) heart rate based on one or more R-R intervals of the heartbeat data, wherein the seizure event is detected by comparing a ratio of the FG heart rate and the BG heart rate to a seizure detection threshold.

17. The medical device of claim 13 , wherein the processor is configured to detect an indication of noise in the heartbeat data, wherein in response to the noise in the heartbeat data increasing, the processor determines the value of the weighting factor such that an effect of prior heartbeat data on the modified heartbeat data is decreased, and wherein, in response to the noise in the heartbeat data decreasing, the processor determines the value of the weighting factor such that the effect of the prior heartbeat data on the modified heartbeat data is increased.

18. The medical device of claim 13 , wherein the processor, in response to the detection of the seizure event, provides a signal to at least one of stimulation device disposed to provide stimulation to tissue of the patient, a signal indicating the occurrence of the seizure event, and a signal initiating the recording of the seizure event.

19. The medical device of claim 13 , wherein activity data includes accelerometer data, body temperature data, electromyography data, perspiration data, impedance data, or a combination thereof.

20. The medical device of claim 13 , wherein, in response to the activity data indicating an increased activity level of the patient, the processor determines the value of the weighting factor such that an effect of prior heartbeat data on the modified heartbeat data is decreased.

21. A non-transitory computer-readable medium storing instructions that are executable by a processor to cause the processor to perform operations including:

receiving heartbeat data of a patient;

receiving activity data of the patient, wherein the activity data includes an activity value related to an activity level of the patient that is measured independently of the heartbeat data;

determining one of a plurality of activity value ranges to which the activity value belongs;

determining a weighting factor based on the determined activity value range, each of the plurality of activity value ranges associated with a different one of a plurality of predetermined weighting factors;

determining modified heartbeat data by applying the weighting factor to at least a portion of the heartbeat data; and

detecting a seizure event based on the modified heartbeat data.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
CHANGE OF NAME Recorded Jun 29, 2020
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 053306/0229 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2014
From: SABESAN, SHIVKUMAR
To: CYBERONICS, INC.
Reel/Frame 032761/0979 →